BibTeX
CSL-JSON
MLA
Harvard
Non-nucleoside reverse transcriptase inhibitor (NNRTI) cross-resistance: implications for preclinical evaluation of novel NNRTIs and clinical genotypic resistance testing
release_nm5knwzcgfgwllbal3r5njdm3a
by
George L. Melikian, Soo-Yon Rhee, Vici Varghese, Danielle Porter, Kirsten White, Jonathan Taylor, William Towner, Paolo Troia, Jeffrey Burack, Edwin DeJesus, Gregory K. Robbins, Kristin Razzeca (+5 others)
Published
in Journal of Antimicrobial Chemotherapy by Oxford University Press (OUP).
2013 Volume 69, p12-20
Archived Files and Locations
application/pdf 478.2 kB
file_lenkambqdvanxpeormtblclnnm
|
escholarship.org (web) web.archive.org (webarchive) |
application/pdf 478.7 kB
file_iitgnqo3f5hy5n2sg74n6b3loy
|
web.archive.org (webarchive) cloudfront.escholarship.org (web) |
application/pdf 450.0 kB
file_5wedoj37cra33k4eph3hsw6f6i
|
web.archive.org (webarchive) hivdb.stanford.edu (web) |
Read Archived PDF
Preserved and Accessible
Work Entity
access all versions, variants, and formats of this works (eg, pre-prints)
access all versions, variants, and formats of this works (eg, pre-prints)
Cite This
Lookup Links
oaDOI/unpaywall (OA fulltext)
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar
Crossref Metadata (via API)
Worldcat
SHERPA/RoMEO (journal policies)
wikidata.org
CORE.ac.uk
Semantic Scholar
Google Scholar